Leukemia inhibitory factor is involved in the pathogenesis of NSCLC through activation of the STAT3 signaling pathway-Reference-Cited by-同舟云学术

Leukemia inhibitory factor is involved in the pathogenesis of NSCLC through activation of the STAT3 signaling pathway

Published:2021-07-14 Issue:3 Volume:22 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Wang Huaying¹,Si Sai'nv¹,Jiang Mingjun²,Chen Liping¹,Huang Kefeng²,Yu Wanjun¹

Affiliation:

1. Department of Respiratory and Critical Care Medicine, People's Hospital Affiliated to Ningbo University, Yinzhou People's Hospital, Ningbo, Zhejiang 315040, P.R. China

2. Department of Thoracic Surgery, People's Hospital Affiliated to Ningbo University, Yinzhou People's Hospital, Ningbo, Zhejiang 315040, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. STAT3-specific nanocarrier for shRNA/drug dual delivery and tumor synergistic therapy;Bioactive Materials;2024-11

2. Cancer-associated fibroblasts promote the malignant development of lung cancer through the FOXO1 protein/LIF signaling;International Journal of Biological Macromolecules;2024-09

3. A mechanistic PK/PD model of AZD0171 (anti‐LIF) to support Phase II dose selection;CPT: Pharmacometrics & Systems Pharmacology;2024-07-23

4. Identification and genetic validation of leukemia inhibitory factor super‐enhancers in acute respiratory distress syndrome and lung cancer;Cell Biochemistry and Function;2024-05-17

5. Expression of cytokines in pleural effusions and corresponding cell lines of small cell lung cancer;Translational Lung Cancer Research;2024-01